RESUMO
PURPOSE: We hypothesized that inducibility of the VT responsible for ICD therapies at the end of RFCA, would also be associated with a differential risk, depending on left ventricular function. METHODS: We retrospectively studied 66 patients with previous myocardial infarction and with ICD who also underwent RFCA for recurrent refractory VTs. RESULTS: During the follow-up only 19 patients (29%) showed VTs. Among patients with ejection fraction (EF)